Innovent and SanegeneBio collaborate to develop siRNA drug for treatment of hypertension
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Furthering cell therapy ambition across oncology and autoimmune diseases
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Subscribe To Our Newsletter & Stay Updated